- Home
- ONCY vs SHMD Comparison
ONCY vs SHMD Comparison
Compare ONCY & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- SHMD
- Stock Information
- Founded
- ONCY 1998
- SHMD 1864
- Country
- ONCY Canada
- SHMD Germany
- Employees
- ONCY N/A
- SHMD N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- SHMD
- Sector
- ONCY Health Care
- SHMD
- Exchange
- ONCY Nasdaq
- SHMD Nasdaq
- Market Cap
- ONCY 89.7M
- SHMD 102.1M
- IPO Year
- ONCY 1999
- SHMD N/A
- Fundamental
- Price
- ONCY $1.36
- SHMD $2.38
- Analyst Decision
- ONCY Strong Buy
- SHMD
- Analyst Count
- ONCY 5
- SHMD 0
- Target Price
- ONCY $5.00
- SHMD N/A
- AVG Volume (30 Days)
- ONCY 1.3M
- SHMD 32.9K
- Earning Date
- ONCY 11-11-2025
- SHMD 01-01-0001
- Dividend Yield
- ONCY N/A
- SHMD N/A
- EPS Growth
- ONCY N/A
- SHMD N/A
- EPS
- ONCY N/A
- SHMD N/A
- Revenue
- ONCY N/A
- SHMD $85,165,542.00
- Revenue This Year
- ONCY N/A
- SHMD N/A
- Revenue Next Year
- ONCY N/A
- SHMD N/A
- P/E Ratio
- ONCY N/A
- SHMD N/A
- Revenue Growth
- ONCY N/A
- SHMD N/A
- 52 Week Low
- ONCY $0.33
- SHMD $1.86
- 52 Week High
- ONCY $1.53
- SHMD $4.40
- Technical
- Relative Strength Index (RSI)
- ONCY 64.50
- SHMD 47.47
- Support Level
- ONCY $1.20
- SHMD $2.00
- Resistance Level
- ONCY $1.44
- SHMD $2.48
- Average True Range (ATR)
- ONCY 0.11
- SHMD 0.23
- MACD
- ONCY 0.01
- SHMD -0.00
- Stochastic Oscillator
- ONCY 81.40
- SHMD 51.37
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).